Simple tests could spot Alzheimer's years early?

NCT ID NCT03136679

Completed Knowledge-focused Sponsor: Baylor Research Institute Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed study looked for chemical markers in blood and urine that could help detect Alzheimer's disease early. Researchers analyzed samples from 95 people with mild cognitive impairment or Alzheimer's, comparing them to healthy older adults. The goal was to find biomarkers that could distinguish between normal aging and different stages of Alzheimer's, potentially leading to a simple screening test in the future.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this research could point toward a simple blood or urine test to detect Alzheimer's disease early, before severe symptoms appear.
What could go wrong: This is an early, observational study with only 95 participants. Finding reliable biomarkers is challenging, and results may not lead to a practical test for many years.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Alzheimer disease Cognitive Dysfunction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ALZHEIMER DISEASE MILD COGNITIVE IMPAIRMENT

Contacts and locations

Show contact details

Locations

Baylor AT&T Memory Center

Dallas, Texas, 75231, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.